Inspire Medical Systems (INSP) Cash from Operations (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Cash from Operations data on file, last reported at 12849000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 291.69% year-over-year to 12849000.0; the trailing twelve-month figure through Mar 2026 stood at 136528000.0 (up 19.05% YoY), and the FY2025 full-year result was 116976000.0, down 10.19% from the prior year.
• Cash from Operations declined to 12849000.0 in Q1 2026, from 52469000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 69181000.0 in Q4 2024 to a low of 12748000.0 in Q1 2022.
• A 5-year average of 17429000.0 and a median of 8860000.0 in 2024 frame the typical range for Cash from Operations.
• Peak annual rise in Cash from Operations reached 3541.03% in 2025, while the deepest fall reached 175.65% in 2025.
• Tracing INSP's Cash from Operations over 5 years: stood at 19269000.0 in 2022, then slipped by 10.39% to 17267000.0 in 2023, then surged by 300.65% to 69181000.0 in 2024, then declined by 24.16% to 52469000.0 in 2025, then slumped by 75.51% to 12849000.0 in 2026.
• Business Quant data shows INSP's Cash from Operations at 12849000.0 in Q1 2026, 52469000.0 in Q4 2025, and 68526000.0 in Q3 2025.